Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis

Journal of Hepatology

Volumn 55, Issue 4, 2011, Pages 756-761

  Terrier, Benjamin ^a,b   Carrat, Fabrice ^c   Geri, Guillaume ^a,b   Pol, Stanislas ^d   Piroth, Lionel ^e   Halfon, Philippe ^f   Poynard, Thierry ^g   Souberbielle, Jean Claude ^h   Cacoub, Patrice ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b CNRS   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d Laboratoire Alphabio ^*  (France)

^e UNIVERSITÉ DE BOURGOGNE   (France)

^f Laboratoire Alphabio   (France)

^g Groupe Hospitalier Pitié Salpêtrire   (France)

^h HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

25 OH vitamin D; Chronic hepatitis; Hepatitis C virus; Human immunodeficiency virus; Severe fibrosis

Indexed keywords

ALPHA 2 MACROGLOBULIN; CALCIFEDIOL; EFAVIRENZ; PEGINTERFERON ALPHA2B; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN;

ADULT; ANTIVIRAL THERAPY; ARTICLE; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NONHUMAN; PRIORITY JOURNAL; VIRUS DETECTION; VITAMIN BLOOD LEVEL;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; DRUG MONITORING; FEMALE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; INTERFERON-ALPHA; LIVER CIRRHOSIS; MALE; PREVALENCE; RIBAVIRIN; SEVERITY OF ILLNESS INDEX; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 79959293590     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.01.041     Document Type: Article

References (32)

1. G.M. Lauer, and B.D. Walker Hepatitis C virus infection N Engl J Med 345 2001 41 52 (Pubitemid 32634271)
2. M.J. Alter, D. Kruszon-Moran, O.V. Nainan, G.M. McQuillan, F. Gao, and L.A. Moyer The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 N Engl J Med 341 1999 556 562 (Pubitemid 29384163)
3. E. Rosenthal, D. Salmon-Ceron, C. Lewden, V. Bouteloup, G. Pialoux, and F. Bonnet Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalite 2005 survey, ANRS EN19) HIV Med 10 2009 282 289
4. E. Rosenthal, M. Poiree, C. Pradier, C. Perronne, D. Salmon-Ceron, and L. Geffray Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study) AIDS 17 2003 1803 1809 (Pubitemid 37000098)
5. P. Cacoub, L. Geffray, E. Rosenthal, C. Perronne, P. Veyssier, and G. Raguin Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997 Clin Infect Dis 32 2001 1207 1214 (Pubitemid 32381124)
6. S.C. Darby, D.W. Ewart, P.L. Giangrande, R.J. Spooner, C.R. Rizza, and G.M. Dusheiko Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation Lancet 350 1997 1425 1431 (Pubitemid 28036863)
7. B. Soto, A. Sanchez-Quijano, L. Rodrigo, J.A. del Olmo, M. Garcia-Bengoechea, and J. Hernandez-Quero Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis J Hepatol 26 1997 1 5 (Pubitemid 27072597)
8. S. Petta, C. Camma, C. Scazzone, C. Tripodo, V. Di Marco, and A. Bono Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C Hepatology 51 2010 1158 1167
9. Abu-Mouch SM, Fireman Z, Jarchovsky J, Assy N. The beneficial effect of vitamin D with combined peg interferon and ribavirin for chronic HCV infection. Hepatology 2009; AASLD Annual Congress: Abstract LB20.
10. U.C. Bang, S.A. Shakar, M.F. Hitz, M.S. Jespersen, O. Andersen, and S.D. Nielsen Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: a descriptive cross-sectional study Scand J Infect Dis 42 2010 306 310
11. P. Wasserman, and D.S. Rubin Highly prevalent vitamin D deficiency and insufficiency in an urban cohort of HIV-infected men under care AIDS Patient Care STDS 24 2010 223 227
12. C.J. Van Den Bout-Van Den Beukel, L. Fievez, M. Michels, F.C. Sweep, A.R. Hermus, and M.E. Bosch Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy AIDS Res Hum Retroviruses 24 2008 1375 1382
13. N.J. Mueller, C.A. Fux, B. Ledergerber, L. Elzi, P. Schmid, and T. Dang High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients AIDS 24 2010 1127 1134
14. C. Haug, F. Muller, P. Aukrust, and S.S. Froland Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival J Infect Dis 169 1994 889 893 (Pubitemid 24102128)
15. E. Villamor A potential role for vitamin D on HIV infection? Nutr Rev 64 2006 226 233 (Pubitemid 43953286)
16. F. Carrat, F. Bani-Sadr, S. Pol, E. Rosenthal, F. Lunel-Fabiani, and A. Benzekri Pegylated interferon alfa-2b vs. standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial JAMA 292 2004 2839 2848 (Pubitemid 39628231)
17. P. Bedossa, and T. Poynard An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group Hepatology 24 1996 289 293 (Pubitemid 26260021)
18. F. Imbert-Bismut, V. Ratziu, L. Pieroni, F. Charlotte, Y. Benhamou, and T. Poynard Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study Lancet 357 2001 1069 1075 (Pubitemid 32322537)
19. 125I-labeled tracer Clin Chem 39 1993 529 533 (Pubitemid 23099026)
20. Terrier B, Souberbielle JC, Saadoun D, Geri G, Sne D, Musset L, et al. Low 25-OH vitamin D serum levels correlates with extra-hepatic manifestations in chronic hepatitis C virus infection. Hepatology 2010; AASLD Annual Congress.
21. G. Targher, L. Bertolini, L. Scala, M. Cigolini, L. Zenari, and G. Falezza Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease Nutr Metab Cardiovasc Dis 17 2007 517 524 (Pubitemid 47176859)
22. J.F. Pascual-Pareja, A. Caminoa, C. Larrauri, J. Gonzalez-Garcia, M.L. Montes, and J. Diez HAART is associated with lower hepatic necroinflammatory activity in HIV-hepatitis C virus-coinfected patients with CD4 cell count of more than 350 cells/μl at the time of liver biopsy AIDS 23 2009 971 975
23. M. Wolf, J. Betancourt, Y. Chang, A. Shah, M. Teng, and H. Tamez Impact of activated vitamin D and race on survival among hemodialysis patients J Am Soc Nephrol 19 2008 1379 1388
24. C.P. Kovesdy, S. Ahmadzadeh, J.E. Anderson, and K. Kalantar-Zadeh Association of activated vitamin D treatment and mortality in chronic kidney disease Arch Intern Med 168 2008 397 403 (Pubitemid 351350586)
25. X. Tan, Y. Li, and Y. Liu Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy J Am Soc Nephrol 17 2006 3382 3393 (Pubitemid 44865281)
26. X. Tan, Y. Li, and Y. Liu Therapeutic role and potential mechanisms of active Vitamin D in renal interstitial fibrosis J Steroid Biochem Mol Biol 103 2007 491 496 (Pubitemid 46401277)
27. J.N. Artaza, and K.C. Norris Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells J Endocrinol 200 2009 207 221
28. A.M. Ramirez, C. Wongtrakool, T. Welch, A. Steinmeyer, U. Zugel, and J. Roman Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cells J Steroid Biochem Mol Biol 118 2010 142 150
29. P.M. Timms, N. Mannan, G.A. Hitman, K. Noonan, P.G. Mills, and D. Syndercombe-Court Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM 95 2002 787 796 (Pubitemid 36032948)
30. M.R. von Essen, M. Kongsbak, P. Schjerling, K. Olgaard, N. Odum, and C. Geisler Vitamin D controls T cell antigen receptor signaling and activation of human T cells Nat Immunol 11 2010 344 349
31. T.T. Brown, and G.A. McComsey Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D Antivir Ther 15 2010 425 429
32. S. Mehta, D.J. Hunter, F.M. Mugusi, D. Spiegelman, K.P. Manji, and E.L. Giovannucci Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal vitamin D status in Tanzania J Infect Dis 200 2009 1022 1030